Browse result page of THPdb

The total number entries retrieved from this search are 15

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
1537	Th1116	Canakinumab	H-GAMMA-1 (VH(1-118) Full view	842	IIIb	Immunological	ILARISÂÂÂ	Novartis Pharmaceuticals	White, preservative-free, lyophilized powder	Subcutaneous injection	Anti-Inflammatory Agents and Monoclonal antibodies	Interleukin-1 beta
1548	Th1117	Ipilimumab	Heavy chain: QVQLVES Full view	663	IIIc	Cancer	YERVOY	Bristol-Myers Squibb	Sterile, preservative-free, clear to slightly opalescent, colorless to pale-yellow solution	N.A.	Antineoplastic Agents and Monoclonal antibodies	Cytotoxic T-lymphocyte protein 4
1560	Th1121	Pertuzumab	light chain DIQMTQSP Full view	664	IIIc	Cancer	Perjeta	Genentech	Sterile, clear to slightly opalescent, colorless to pale brown liquid	Intravenous infusion	Monoclonal antibodies	Receptor tyrosine-protein kinase erbB-2
1570	Th1123	Denosumab	Heavy chain EVQLLESG Full view	664	IIIc	Osteological	Xgeva	Amgen.	Sterile, preservative-free, clear, colorless to pale yellow solution	N.A.	Bone Density Conservation Agents and Monoclonal antibodies	Tumor necrosis factor ligand superfamily member 11
1571	Th1123	Denosumab	Heavy chain EVQLLESG Full view	664	IIIc	Osteological	Prolia	Amgen.	Sterile, preservative-free, clear, colorless to pale yellow solution	N.A.	Bone Density Conservation Agents and Monoclonal antibodies	Tumor necrosis factor ligand superfamily member 11
1583	Th1125	Golimumab	N.A. Full view	0	IIb	Immunological	Simponi Injection	N.A.	Clear to slightly opalescent, colorless to light yellow solution	Subcutaneous injection	Antipsoriatic Agents and Monoclonal antibodies and TNF inhibitor	Tumor necrosis factor
1584	Th1125	Golimumab	N.A. Full view	0	IIb	Immunological	Simponi Injection	N.A.	Sterile concentrated solution of the golimumab antibody	Intravenous infusion	Antipsoriatic Agents and Monoclonal antibodies and TNF inhibitor	Tumor necrosis factor
1609	Th1132	Belimumab	N.A. Full view	0	IIa	Immunological	Benlysta	GlaxoSmithKline	Sterile, white to off-white, preservative-free, lyophilized powder	Intravenous infusion	Monoclonal antibodies	Tumor necrosis factor ligand superfamily member 13B
1627	Th1138	Raxibacumab	N.A. Full view	0	IIa	Immunological/Infectious	RAXIBACUMAB	GSK	Sterile, liquid formulation in single-dose vials	N.A.	Anti-Infective Agents and Monoclonal antibodies	Protective antigen
1708	Th1170	Blinatumomab	DIQLTQSPASLAVSLGQRAT Full view	504	IIIc	Cancer/Genetic	Blincyto	AMGEN	Lyophilized Powder for intravenous administration	Intravenous	Antineoplastic Agents, Immunosuppressive Agents, Monoclonal antibodies, Antineoplastic and Immunomodulating Agents	B-lymphocyte antigen CD19; T-cell surface glycoprotein CD3 delta chain
1828	Th1218	Anti-thymocyte Globulin (Equine)	NA Full view	0	IIIb	Immunological Disorders	ATGAM	NA	Solid	Intravenous	Antibody	NA
1829	Th1219	Anti-thymocyte Globulin (Rabbit)	NA Full view	0	IIIb	Immunological Disorders	ATG-Fresenius	Genzyme Inc.	Concentrate for solution for infusion.	Intravenous	Antibody	T-cell surface glycoprotein CD1a, Major histocompatibility complex class I-related gene protein, Integrin alpha-L, T-lymphocyte activation antigen CD86, Low affinity immunoglobulin gamma Fc region receptor II-b, T-cell surface glycoprotein CD4, Integrin beta-1, Integrin alpha-V, Integrin beta-3
1837	Th1226	Dinutuximab	NA Full view	0	IIIc	Cancer	unituxin	NA	sterile, preservative-free, clear/colorless to slightly opalescent solution	Intravenous	Antibody, Immunosuppresive agent, Antineoplastic agent	Ganglioside GD2 (small molecule)
1842	Th1230	Human Varicella-Zoster Immune Globulin	NA Full view	0	IIIa	Infectious Disease	VARIZIG	NA	lyophilized powder for solution	Intramuscular	Antibody	varicella zoster virus
1843	Th1231	Ibritumomab tiuxetan	Heavy chain: QAYLQQS Full view	652	IIIc	Cancer	Zevalin	Spectrum Pharmaceuticals B.V.	Colourless Solution	Intravenous	Antibody, Immunosuppressive Agents	B-lymphocyte antigen CD20, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, Complement C1s subcomponent, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c